Pierre Gholam(@pgholam) 's Twitter Profileg
Pierre Gholam

@pgholam

hepatologist focused on liver cancer. occasional healer, wannabe world traveler, husband and dad. opinions mine and do not reflect views of my employer.

ID:38775608

calendar_today09-05-2009 02:14:22

3,9K Tweets

1,1K Followers

348 Following

Pierre Gholam(@pgholam) 's Twitter Profile Photo

Grateful to all our oncology nurses who expertly administer life saving treatments and monitor patients with compassion and care. Happy

account_circle
Pierre Gholam(@pgholam) 's Twitter Profile Photo

Thanks to all the moderators and presenters who made this 54th edition of Northeast Ohio Liver Alliance Tavill liver rounds a great success. See you for the next one August 14!

Thanks to all the moderators and presenters who made this 54th edition of @OHIOLIVER Tavill liver rounds a great success. See you for the next one August 14!
account_circle
Pierre Gholam(@pgholam) 's Twitter Profile Photo

The ultimate combination of sustained excellence, leadership, humility, kindness and humor.
Congratulations Nicholas F LaRusso, M.D.
A role model for all of us!

account_circle
Pierre Gholam(@pgholam) 's Twitter Profile Photo

Of all things medicine, no act is judged more critically or harshly than transplantation.
I don’t know if any of the allegations in this ⁦The New York Times⁩ article have merit but a lengthy “expose” with nothing but innuendo doesn’t cut it.
Do better… nytimes.com/2024/04/29/us/…

account_circle
Pierre Gholam(@pgholam) 's Twitter Profile Photo

I understand the federal mandate to release information to patients as soon as it becomes available but there is nothing more cruel than a person reading news of terminal diagnosis the moment you sign a document before you are able to talk to them

account_circle
Pierre Gholam(@pgholam) 's Twitter Profile Photo

This ⁦The New York Times⁩ article makes me sad. It mostly gets it wrong & seems like it was written 10 y ago.

=Fentanyl

When you get serious about treating opioid addiction, the rest follows.

You can’t fix this w/ 4 billion dollars


nytimes.com/2024/04/28/hea…

account_circle
AASLD(@AASLDtweets) 's Twitter Profile Photo

With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-ha…

With deep sadness, AASLD recognizes the passing of a great leader in the field. Dr. Stephen Harrison leaves behind an incredible legacy, particularly in NASH/MASH. Thank you Drs. Rinella, Tetri, and Brunt for your moving tribute, which you can read here: aasld.org/col-stephen-ha…
account_circle
Pierre Gholam(@pgholam) 's Twitter Profile Photo

Life is short, fragile and fleeting…
The hepatology community is truly heartbroken and bereaved by the loss of Dr. Stephen Harrison.
May his family and loved ones be granted solace, comfort and strength
May his memory be an eternal blessing

account_circle
Elliot Tapper(@ebtapper) 's Twitter Profile Photo

Stephen Harrison had a massive, positive, impact on the field. He produced landmarks in the epidemiology of NAFLD/MASLD, non-invasive testing, and he lead the trial that brought us the first FDA-approved drug

Stephen Harrison had a massive, positive, impact on the field. He produced landmarks in the epidemiology of NAFLD/MASLD, non-invasive testing, and he lead the trial that brought us the first FDA-approved drug
account_circle